Sbd

P119 - Hipolipemiante reduz risco de retinopatia em DM2 - Solange Travassos

Informações:

Sinopse

Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database. Diabetes Obes Metab. 2018 Oct;20(10):2351-2360.